Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells. - Test2 - elhamkhani - TriplyDB

Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells.

Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells.

http://www.wikidata.org/entity/Q38820303

about

Transfer RNA-derived small RNAs in the cancer transcriptome Vinca alkaloid drugs promote stress-induced translational repression and stress granule formation.mRNPs meet stress granules.Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules.Principles and Properties of Stress Granules Post-transcriptional regulation of cytokine and growth factor signaling in cancer.Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.DDX3 regulates endoplasmic reticulum stress-induced ATF4 expression.Quantitative Immunofluorescence to Measure Global Localized Translation.Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells.Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells.Methods to Classify Cytoplasmic Foci as Mammalian Stress Granules.

P2860

Q26752293-20BCCB3B-C370-440D-893C-57DDF3011375 Q37327483-C76EE093-471A-4B2D-9103-0E42B5DBA2C9 Q38659834-D53550C4-6E4D-4485-B9E5-2B80F523D43A Q38725826-099D5C80-3FA4-4A1B-8C0E-EB8F17DFD146 Q38862341-12042EE4-3633-4C57-BF09-774C7FF71083 Q39036700-077DC9CD-6BA4-4C4C-A407-5B002782F7AF Q40979497-096B0241-FC69-4868-A656-24B563FBBABB Q47110143-ECB68869-D2AD-415A-B9B2-DF55E888A005 Q47125075-B8025B01-FC98-4273-90AF-EC60F3317D2D Q47855915-3D9CB9D5-CB7D-4DB9-910B-2F2866CB16EB Q49221322-95366C47-1ACC-4EE9-8D15-51316ED432B7 Q50321414-78D11D20-C8F5-4CF8-98EA-A833BDB96E68 Q50965710-E0CE5E11-E065-445A-88F1-0A2C5180D2CB

P2860

Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells.

http://www.wikidata.org/entity/Q38820303

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Sorafenib, a multikinase inhib ...... ules in hepatocarcinoma cells.

@en

type

label

Sorafenib, a multikinase inhib ...... ules in hepatocarcinoma cells.

@en

prefLabel

Sorafenib, a multikinase inhib ...... ules in hepatocarcinoma cells.

@en

P1433

Q38820303-394B13D7-F7FD-4519-BEDE-2F7E113C69AB

P1476

Q38820303-CA06FB00-97C6-41E0-956A-1A51BC38C9E4

P2093

Q38820303-1114CCC7-234C-4B78-BAF8-1EF3CE3BD29D

Q38820303-25CEACC5-1BE6-44CF-AE11-3C21A3289590

Q38820303-7A27AD9F-994D-4478-953A-8E3D15A4BB63

Q38820303-7DE8F1BB-4113-4CBB-83C0-17E65CEC74D6

Q38820303-859A3546-85A1-4A90-B6FA-0EF24392BBAD

Q38820303-85C0127F-EC47-4263-9D84-5730F9B73B97

Q38820303-FCA517EE-71D4-4E8C-95A1-CB5E75E1EEC8

P2860

Q38820303-07C5F1E2-0FB7-49A0-8079-BBC14A23B374

Q38820303-0C1C39BE-77E7-4A95-8303-EA5C449A9126

Q38820303-10C629A7-5700-4804-9AF9-6CA9BD8A47F5

Q38820303-11203ADE-CF02-408C-9ADF-ACC3241B52EC

Q38820303-131CB873-C7B0-4C02-9D3E-DDD33D142C81

Q38820303-17351CED-C822-46D7-B9BD-B329B96EE913

Q38820303-17484409-9672-42F7-865D-269E20B76BA9

Q38820303-19085EE9-434F-40B7-B130-305FA44ACED3

Q38820303-1B2D775B-84A5-45FD-B4B4-9F04016A5B6D

Q38820303-1B3FC886-DB1D-4105-BC6D-E5E51ED260C7

P304

Q38820303-9E167904-9F59-4840-8B11-A6BC6AF77B62

P31

Q38820303-951BDA95-1A21-41CE-B2F8-6E1587A90302

P356

Q38820303-A35B0EAA-5EFE-4571-B86E-040BF97C815A

P407

Q38820303-BD3DD828-503A-44B3-8418-3B85B636A3F1

P433

Q38820303-B237C33B-DAEB-4FBC-9C00-EFB298F02105

P478

Q38820303-FD6D9A78-8422-4DCB-A6E1-AF8C2B8A0CF1

P50

Q38820303-386B33C5-D746-45C7-848C-3679EFC19FAE

P577

Q38820303-8E588A9D-7C92-4897-9683-E70231C6EDEA

P5875

Q38820303-55E939BE-53F0-4FEB-A40E-D42AAF021AC6

P698

Q38820303-09856DD8-C5EF-4CA2-9AFA-CCC1E5D4F7F7

P932

Q38820303-92173CDD-FF18-469C-B9A9-FADDD0F57EC4

P356

ONCOTARGET.5980

P1433

P1476

Sorafenib, a multikinase inhib ...... nules in hepatocarcinoma cells

@en

P2093

Andreanne Savard

http://www.w3.org/2001/XMLSchema#string

Edouard W Khandjian

http://www.w3.org/2001/XMLSchema#string

Laetitia Coudert

http://www.w3.org/2001/XMLSchema#string

Marie-Josée Fournier

http://www.w3.org/2001/XMLSchema#string

Pauline Adjibade

http://www.w3.org/2001/XMLSchema#string

Rachid Mazroui

http://www.w3.org/2001/XMLSchema#string

Valérie Grenier St-Sauveur

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells

Stress granules in the viral replication cycle

Role of HRI in apoptosis resistance

Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (P

Perk is essential for translational regulation and cell survival during the unfolded protein response

Translational control is required for the unfolded protein response and in vivo glucose homeostasis

Autophosphorylation of threonine 485 in the activation loop is essential for attaining eIF2alpha kinase activity of HRI

A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly

Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase

Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice

P304

43927-43943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5980

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Miguel Quévillon Huberdeau

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283717162

http://www.w3.org/2001/XMLSchema#string

P698

26556863

http://www.w3.org/2001/XMLSchema#string

P932

4791277

http://www.w3.org/2001/XMLSchema#string